Publication | Closed Access

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

Hematological MalignancyChromatinHaematopoietic Stem CellsChronic Myeloid LeukaemiaCatalytic ComponentHematologyMedicineMixed-phenotype Acute LeukemiaMyeloid NeoplasiaMalignant Blood DisorderRadiation OncologyStem CellsCell BiologyMyelopoiesisHealth Sciences